The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.
Collaboration with Ability Bhutan Society 2025
Invest fot children continues with the collaboration started with Ability Bhutan Society (ABS) last year. The project aims to promote the social inclusion of children with disabilities, along with their…
see project 
